Skip to main content
logo
Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
0.4428
+0.0547 (14.09%)
At close: Sep 2, 2026, 4:00 PM EDT
0.4182
-0.0246 (-5.56%)
After-hours: Sep 2, 2026, 4:50 PM EDT

Ensysce Biosciences Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
4.55.075.212.232.523.53
Revenue Growth
-39.29%-2.75%133.58%-11.61%-28.54%-10.17%
Gross Profit
-7.89-5.31-2.01-5.36-17.31-1.16
Operating Income
-12.66-10.24-6.73-10.72-24.22-19.87
Net Income
-12.62-10.18-7.99-10.63-25.09-29.89
Earnings Per Share
-1.90-3.98-11.45-70.40-2091.33-
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0.684.313.51.123.1512.26
Total Debt
0.20.310.30.854.4317.21
Net Cash (Debt)
0.4843.20.27-1.29-4.95
Net Cash Growth
-73.15%25.10%1090.16%---
Net Cash Per Share
0.071.574.591.78-107.24-

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-8.86-7.81-7.5-10.78-17.89-8.24
Capital Expenditures
-0.12-0.12----
Free Cash Flow
-8.98-7.93-7.5-10.78-17.89-8.24
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-175.21%-104.81%-38.57%-240.17%--32.82%
Operating Margin
-281.32%-202.13%-129.18%-480.52%-959.91%-562.71%
Pretax Margin
-280.49%-200.85%-153.30%-476.40%-959.33%-825.38%
Profit Margin
-280.48%-200.84%-153.31%-476.39%-994.12%-846.37%
FCF Margin
-199.50%-156.51%-144.00%-483.30%-708.87%-233.41%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
1.690.662.041.501.9132.28